Applied Materials Inc: Form 10-Q for the period ended Jul 30, 2023
Filed with the SEC on Aug 24, 2023 and accepted by EDGAR at Aug 24, 2023, 16:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-05-01 to 2023-07-30 | $6.42bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-10-31 to 2023-07-30 | $19.79bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-05-01 to 2023-07-30 | $3.45bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-10-31 to 2023-07-30 | $10.58bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-05-01 to 2023-07-30 | $2.98bn | us-gaap:GrossProfit |
| Gross profit | 9 months2022-10-31 to 2023-07-30 | $9.21bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-05-01 to 2023-07-30 | $767.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-31 to 2023-07-30 | $2.31bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-05-01 to 2023-07-30 | $1.80bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-31 to 2023-07-30 | $5.68bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-05-01 to 2023-07-30 | $60.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-31 to 2023-07-30 | $180.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-05-01 to 2023-07-30 | $246.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-31 to 2023-07-30 | $692.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-05-01 to 2023-07-30 | $1.56bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-31 to 2023-07-30 | $4.85bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-05-01 to 2023-07-30 | $1.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-31 to 2023-07-30 | $5.73 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-05-01 to 2023-07-30 | $1.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-31 to 2023-07-30 | $5.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-05-01 to 2023-07-30 | 843,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-31 to 2023-07-30 | 846,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-31 to 2023-07-30 | $7.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-31 to 2023-07-30 | $797.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-10-31 to 2023-07-30 | $707.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2022-10-31 to 2023-07-30 | $1.49bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-30 | $6.03bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-30 | $18.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-30 | $30.41bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-30 | $8.22bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-30 | $15.32bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-07-30 | $5.46bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-07-30 | $199.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-07-30 | $15.09bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-07-30 | 836,533,852 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000006951-23-000031. Last ingested by Listed: Oct 26, 2026, 16:35 ET. Listed shows no prices and gives no investment advice.